Correction

Published on 25 Sep 2024

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

in Vaccines and Molecular Therapeutics

Shi Zou
Wei Guo
Songjie Wu
Fangzhao Ming
Yuting Tan
Mengmeng Wu
Weiming Tang
Ke Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494940

356 views

Original Research

Published on 24 Sep 2024

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

in Vaccines and Molecular Therapeutics

Chitra Upadhyay
Priyanka Rao
Mohammad Amin Behzadi
Roya Feyznezhad
Gregory S. Lambert
Rajnish Kumar
Madhu Kumar
Weiming Yang
Xunqing Jiang
Christina C. Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476924

788 views

Original Research

Published on 24 Sep 2024

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B

in Vaccines and Molecular Therapeutics

Shathviga Manoharan
Theo A. Farman
Stavroula Piliou
Pietro Mastroeni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473064

878 views

Original Research

Published on 17 Sep 2024

Tonsil explants as a human in vitro model to study vaccine responses

in Vaccines and Molecular Therapeutics

Elena Bonaiti
Manuele G. Muraro
Philippe A. Robert
Jens Jakscha
Stefan Dirnhofer
Ivan Martin
Christoph T. Berger

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425455

932 views

Original Research

Published on 16 Sep 2024

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

in Vaccines and Molecular Therapeutics

Kohei Togami
Whitney Wolf
Lucas C. Olson
Madison Card
Limei Shen
Alison Schaefer
Kenichi Okuda
Larry Zeitlin
Michael Pauly
Kevin Whaley

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371156

1,015 views

Original Research

Published on 16 Sep 2024

Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection

in Vaccines and Molecular Therapeutics

Yichen Fan
Yueyue He
Yujiao Li
Zhengwei Yin
Juan Shi
Tingting Tian
Kaiyu Shang
Huidong Shi
Fengbo Zhang
Hao Wen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425603

793 views

Original Research

Published on 13 Sep 2024

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

in Vaccines and Molecular Therapeutics

Gabriela M. Escalante
Ivana G. Reidel
Lorraine Z. Mutsvunguma
Simeon Cua
Brenda A. Tello
Esther Rodriguez
Mafalda A. Farelo
Cloe Zimmerman
Murali Muniraju
He Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445209

1,278 views
1 citation

Original Research

Published on 12 Sep 2024

Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans

in Vaccines and Molecular Therapeutics

Jayaum S. Booth
Rekha R. Rapaka
Monica A. McArthur
Stephanie Fresnay
Thomas C. Darton
Christoph J. Blohmke
Claire Jones
Claire S. Waddington
Myron M. Levine
Andrew J. Pollard

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384642

682 views

Review

Published on 12 Sep 2024

Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector

in Vaccines and Molecular Therapeutics

Xinru Luo
Ruiying Liang
Lin Liang
Aoxing Tang
Shaohua Hou
Jiabo Ding
Zibin Li
Xinming Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445387

1,207 views

Original Research

Published on 12 Sep 2024

Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19

in Vaccines and Molecular Therapeutics

Hui Zheng
Cuidan Li
Xiuyu Zheng
Hu-Dachuan Jiang
Yuqing Li
Aihua Yao
Xiaolong Li
Feiyu Wang
Wenqing Liu
Xiang Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461419

807 views

Review

Published on 11 Sep 2024

Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection

in Vaccines and Molecular Therapeutics

Kaiwen Yang
Youqin Zeng
Xinyu Wu
Jia Li
Jinlin Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392898

1,238 views

Brief Research Report

Published on 09 Sep 2024

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E

in Vaccines and Molecular Therapeutics

Yang Liu
Xiaoyu Liu
Weiwei Chen
Yunzhou Yu
Jianghui Meng
Jiafu Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469919

816 views

Mini Review

Published on 05 Sep 2024

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies

in Vaccines and Molecular Therapeutics

Maya Weitzen
Mohammad Shahbazy
Saketh Kapoor
Etienne Caron

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442783

2,410 views

Original Research

Published on 04 Sep 2024

The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment

in Vaccines and Molecular Therapeutics

Edina Komlodi-Pasztor
Marta Escarra-Senmarti
Danielle A. Bazer
Aastha Bhatnagar
Carlos A. Perez Heydrich
Marcus Messmer
Richard F. Ambinder
Douglas E. Gladstone
Laura Clayton
Amy Goodrich

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433442

2,632 views

Original Research

Published on 03 Sep 2024

Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies

in Vaccines and Molecular Therapeutics

Wei-Chun Chen
Shu-Yu Hu
Chao-Min Cheng
Ching-Fen Shen
Hui-Yu Chuang
Chin-Ru Ker
Der-Ji Sun
Ching-Ju Shen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415561

802 views

Original Research

Published on 03 Sep 2024

Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database

in Vaccines and Molecular Therapeutics

Wei Liu
Shuzhi Lin
Xiaoying Zhu
Lin Yin
Qian Liu
Shuang Lei
Bianling Feng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433075

1,508 views
1 citation

Navigation group

Articles

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B

Tonsil explants as a human in vitro model to study vaccine responses

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans

Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector

Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19

Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies

The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment

Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies

Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database